Yaxiaer Yalikun

Dr. Yaxiaer Yalikun

Materials Science, Nara Institute of Science and Technology, Nara, Japan
orcid
This site does not contain all of my works, please check my ...

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Cell
Verified
Journal Article
Closed access
NNNao Nitta
Nao Nitta
TSTakeaki Sugimura
Takeaki Sugimura
AIAkihiro Isozaki
Akihiro Isozaki
HMHideharu Mikami
Hideharu Mikami
KHKei Hiraki
Kei Hiraki
KGKeisuke Goda
Keisuke Goda

19 July 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YSYuta Suzuki
Yuta Suzuki
KKKoya Kobayashi
Koya Kobayashi
YWYoshifumi Wakisaka
Yoshifumi Wakisaka
DDDinghuan Deng
Dinghuan Deng
STShunji Tanaka
Shunji Tanaka
YOYasuyuki Ozeki
Yasuyuki Ozeki
Combining the strength of flow cytometry with fluorescence imaging and digital image analysis, imaging flow cytometry is a powerful tool in diverse fields including cancer biology, immunology, drug discovery, microbiology, and metabolic engineering. It enables measurements and statistical analyses of chemical, structural, and morphological phenotypes of numerous living cells to provide systematic insights into biological processes. However, its utility is constrained by its requirement of fluorescent labeling for phenotyping. Here we present label-free chemical imaging flow cytometry to overcome the issue. It builds on a pulse pair-resolved wavelength-switchable Stokes laser for the fastest-to-date multicolor stimulated Raman scattering (SRS) microscopy of fast-flowing cells on a 3D acoustic focusing microfluidic chip, enabling an unprecedented throughput of up to ∼140 cells/s. To show its broad utility, we use the SRS imaging flow cytometry with the aid of deep learning to study the metabolic heterogeneity of microalgal cells and perform marker-free cancer detection in blood.

1 March 2019 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
YSYigang Shen
Yigang Shen
Yaxiaer YalikunYaxiaer Yalikun
Yaxiaer Yalikun
YTYo Tanaka
Yo Tanaka

5 November 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MAMosha Abulaiti
Mosha Abulaiti
Yaxiaer YalikunYaxiaer Yalikun
Yaxiaer Yalikun
KMKozue Murata
Kozue Murata
ASAsako Sato
Asako Sato
MSMustafa M. Sami
Mustafa M. Sami
HMHidetoshi Masumoto
Hidetoshi Masumoto
Human iPS cell (iPSC)-derived cardiomyocytes (CMs) hold promise for drug discovery for heart diseases and cardiac toxicity tests. To utilize human iPSC-derived CMs, the establishment of three-dimensional (3D) heart tissues from iPSC-derived CMs and other heart cells, and a sensitive bioassay system to depict physiological heart function are anticipated. We have developed a heart-on-a-chip microdevice (HMD) as a novel system consisting of dynamic culture-based 3D cardiac microtissues derived from human iPSCs and microelectromechanical system (MEMS)-based microfluidic chips. The HMDs could visualize the kinetics of cardiac microtissue pulsations by monitoring particle displacement, which enabled us to quantify the physiological parameters, including fluidic output, pressure, and force. The HMDs demonstrated a strong correlation between particle displacement and the frequency of external electrical stimulation. The transition patterns were validated by a previously reported versatile video-based system to evaluate contractile function. The patterns are also consistent with oscillations of intracellular calcium ion concentration of CMs, which is a fundamental biological component of CM contraction. The HMDs showed a pharmacological response to isoproterenol, a β-adrenoceptor agonist, that resulted in a strong correlation between beating rate and particle displacement. Thus, we have validated the basic performance of HMDs as a resource for human iPSC-based pharmacological investigations.

1 December 2020 in Biotechnology Advances
Verified
Journal Article
Closed access
YHYansheng Hao
Yansheng Hao
SCShaokoon Cheng
Shaokoon Cheng
YTYo Tanaka
Yo Tanaka
YHYoichiroh Hosokawa
Yoichiroh Hosokawa
Yaxiaer YalikunYaxiaer Yalikun
Yaxiaer Yalikun
Ming LiMing Li
Ming Li

7 November 2019 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
TZTianlong Zhang
Tianlong Zhang
ZHZhen-Yi Hong
Zhen-Yi Hong
Shiyang TangShiyang Tang
Shiyang Tang
WLWeihua Li
Weihua Li
David W. InglisDavid W. Inglis
David W. Inglis
Ming LiMing Li
Ming Li
Sub-micrometer particles (0.10–1.0 μm) are of great significance to study, e.g., microvesicles and protein aggregates are targets for therapeutic intervention, and sub-micrometer fluorescent polystyrene (PS) particles are used as probes for diagnostic imaging. Focusing of sub-micrometer particles – precisely control over the position of sub-micrometer particles in a tightly focused stream – has a wide range of applications in the field of biology, chemistry and environment, by acting as a prerequisite step for downstream detection, manipulation and quantification. Microfluidic devices have been attracting great attention as desirable tools for sub-micrometer particle focusing, due to their small size, low reagent consumption, fast analysis and low cost. Recent advancements in fundamental knowledge and fabrication technologies have enabled microfluidic focusing of particles at sub-micrometer scale in a continuous, label-free and high-throughput manner. Microfluidic methods for the focusing of sub-micrometer particles can be classified into two main groups depending on whether an external field is applied: 1) passive methods, which utilize intrinsic fluidic properties without the need of external actuation, such as inertial, deterministic lateral displacement (DLD), viscoelastic and hydrophoretic focusing; and 2) active methods, where external fields are used, such as dielectrophoretic, thermophoretic, acoustophoretic and optical focusing. This article mainly reviews the studies on the focusing of sub-micrometer particles in microfluidic devices over the past 10 years. It aims to bridge the gap between the focusing of micrometer and nanometer scale (1.0–100 nm) particles and to improve the understanding of development progress, current advances and future prospects in microfluidic focusing techniques.